Biotech News

Alkermes Announces Appointment of Anne C. Whitaker to Board of Directors

Alkermes plc (ALKS)Alkermes plcCompany update

DUBLIN --(BUSINESS WIRE)--Sep. 16, 2026-- Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company’s Board of Directors (the Board). Ms. Whitaker is a seasoned biopharmaceutical executive and experienced board director who brings

Related news

Alkermes plc

Alkermes is a biopharmaceutical company focused on neuroscience, addiction medicine, and specialty therapeutics. Its portfolio combines commercial products and development programs across CNS and related areas.

Recent company news

Stock data

Close
46.71 USD
Market cap
6.89B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States